The patients with rheumatoid arthritis with the slow NAT2 acetylator genotypes have been shown to have more side effects than fast acetylator genotypes when taking SASP.
同时也有研究发现慢型乙酰化表型的风湿性关节炎患者在服用SASP后，与快型乙酰化表型患者相比，副反应发生率明显升高。
The patients with rheumatoid arthritis with the slow NAT2 acetylator genotypes have been shown to have more side effects than fast acetylator genotypes when taking SASP.
同时也有研究发现慢型乙酰化表型的风湿性关节炎患者在服用SASP后，与快型乙酰化表型患者相比，副反应发生率明显升高。
应用推荐